Astante Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Astante Therapeutics General Information

Description

Developer of novel, immunotherapy-based drugs designed to treat multidrug-resistant cancers. The company develops new treatments for multidrug-resistant cancers, enabling healthcare institutions to treat cancer efficiently.

Contact Information

Website
www.astantetherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 120 North Street
  • Suite 270A
  • Spokane, WA 99202
  • United States
+1 (509)
Primary Industry
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 120 North Street
  • Suite 270A
  • Spokane, WA 99202
  • United States
+1 (509)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astante Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2022 Completed Startup
To view Astante Therapeutics’s complete valuation and funding history, request access »

Astante Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Spinout Space Accelerator/Incubator
To view Astante Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Astante Therapeutics FAQs

  • When was Astante Therapeutics founded?

    Astante Therapeutics was founded in 2021.

  • Where is Astante Therapeutics headquartered?

    Astante Therapeutics is headquartered in Spokane, WA.

  • What industry is Astante Therapeutics in?

    Astante Therapeutics’s primary industry is Drug Discovery.

  • Is Astante Therapeutics a private or public company?

    Astante Therapeutics is a Private company.

  • What is Astante Therapeutics’s current revenue?

    The current revenue for Astante Therapeutics is .

  • Who are Astante Therapeutics’s investors?

    Spinout Space has invested in Astante Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process